May 09, 2023 / 03:40PM GMT
Geoffrey Christopher Meacham - BofA Securities, Research Division - Research Analyst
Welcome to the first morning of the BofA Healthcare Conference. My name is Geoff Meacham. I'm a senior biopharma analyst, and we are excited to have Bristol-Myers here. And Adam Lenkowsky is here, who recently was promoted to EVP, Head of Commercial. So congratulations.
Adam Lenkowsky - Bristol-Myers Squibb Company - Executive VP, Chief Commercialization Officer & Head of U.S. Oncology
Thank you, Geoff. Great to be here.
Questions and Answers:
Geoffrey Christopher Meacham - BofA Securities, Research Division - Research AnalystLet's just kick off with that. Like so give us -- as you evolve into the new role, you already know a lot of the commercial business around the world and different therapeutic areas. Give us kind of your -- what would be your top 3 kind of list of priorities as you look to the back half of this year and into next?
Adam Lenkowsky - Bristol-Myers Squibb Company - Executive